ArticleBone & joint research2022

Auraptene ameliorates osteoporosis by inhibiting RANKL/NFATc1 pathway-mediated bone resorption based on network pharmacology and experimental evaluation.

Mi H Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.